New Developments in MPN Research 2023
by David Wallace Patients are Asking – MPN Specialist Dr. Srdan Verstovsek – Episode 3 of 3 Interview with MPN expert, Dr. Srdan Verstovsek from ASH 2022. Learn about an exciting new anti-mutant calreticulin (CALR) targeted monoclonal antibody that may lead to a molecular response in MF and ET. What were some of the highlights […]